[PHARMA] YoY Quarter Result on 30-Jun-2020 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Aug-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
30-Jun-2020 [#2]
Profit Trend
QoQ- -55.45%
YoY- 7.52%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 848,734 761,102 1,177,123 645,763 601,890 582,729 517,967 8.57%
PBT 6,342 4,521 22,244 14,326 12,481 11,970 10,150 -7.53%
Tax -4,018 -3,607 -8,356 -4,719 -3,219 -6,204 -399 46.92%
NP 2,324 914 13,888 9,607 9,262 5,766 9,751 -21.25%
-
NP to SH 1,961 722 13,704 9,979 9,281 5,394 9,520 -23.14%
-
Tax Rate 63.36% 79.78% 37.57% 32.94% 25.79% 51.83% 3.93% -
Total Cost 846,410 760,188 1,163,235 636,156 592,628 576,963 508,216 8.86%
-
Net Worth -137,571 406,087 357,275 357,891 518,564 519,642 542,147 -
Dividend
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Div - 6,549 19,630 6,530 6,514 10,392 10,376 -
Div Payout % - 907.17% 143.25% 65.45% 70.19% 192.67% 108.99% -
Equity
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Net Worth -137,571 406,087 357,275 357,891 518,564 519,642 542,147 -
NOSH 1,310,208 1,309,126 261,991 261,705 261,229 259,821 259,400 30.97%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin 0.27% 0.12% 1.18% 1.49% 1.54% 0.99% 1.88% -
ROE 0.00% 0.18% 3.84% 2.79% 1.79% 1.04% 1.76% -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 64.78 58.10 89.95 247.20 230.98 224.28 199.68 -17.09%
EPS 0.15 0.06 1.05 3.82 3.56 2.08 3.67 -41.29%
DPS 0.00 0.50 1.50 2.50 2.50 4.00 4.00 -
NAPS -0.105 0.31 0.273 1.37 1.99 2.00 2.09 -
Adjusted Per Share Value based on latest NOSH - 261,705
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 58.89 52.81 81.67 44.81 41.76 40.43 35.94 8.57%
EPS 0.14 0.05 0.95 0.69 0.64 0.37 0.66 -22.76%
DPS 0.00 0.45 1.36 0.45 0.45 0.72 0.72 -
NAPS -0.0955 0.2818 0.2479 0.2483 0.3598 0.3605 0.3762 -
Price Multiplier on Financial Quarter End Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 -
Price 0.37 0.595 5.29 2.22 2.84 2.88 4.58 -
P/RPS 0.57 1.02 5.88 0.90 1.23 1.28 2.29 -20.67%
P/EPS 247.21 1,079.54 505.18 58.12 79.74 138.73 124.80 12.06%
EY 0.40 0.09 0.20 1.72 1.25 0.72 0.80 -10.90%
DY 0.00 0.84 0.28 1.13 0.88 1.39 0.87 -
P/NAPS 0.00 1.92 19.38 1.62 1.43 1.44 2.19 -
Price Multiplier on Announcement Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 11/08/23 19/08/22 20/08/21 19/08/20 23/08/19 17/08/18 16/08/17 -
Price 0.42 0.595 0.925 4.42 2.66 3.11 4.19 -
P/RPS 0.65 1.02 1.03 1.79 1.15 1.39 2.10 -17.74%
P/EPS 280.62 1,079.54 88.34 115.71 74.69 149.80 114.17 16.16%
EY 0.36 0.09 1.13 0.86 1.34 0.67 0.88 -13.83%
DY 0.00 0.84 1.62 0.57 0.94 1.29 0.95 -
P/NAPS 0.00 1.92 3.39 3.23 1.34 1.56 2.00 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment